1. Ma GH, Ye Y, Zhang D, Xu X, Si P, Peng JL, Xiao YL, Cao RY, Yin YL, Chen J, Zhao LX, Zhou Y*, Zhong W, Liu H, Luo XM*, Chen LL*, Shen X. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening. Eur J Med Chem. 2016 Oct 11;124:981-991. 2. Xu X, Xu X, Liu P, Zhu ZY, Chen J, Chen LL*, Hu LH*, Shen X*. Structural basis for small molecule NDB as a selective antagonist of Farnesoid X receptor (FXRa) in stabilizing the homodimerization of the receptor. J Biol Chem. 2015 Aug 7;290(32):19888-99. 3. Huang H, Si P, Wang L, Xu Y, Zhua J, Jiang HL, Li WH*, Chen LL*, Li J*. Design, synthesis, and biological evaluation of novel non-steroidal FXR antagonists: molecular bases of FXR antagonism. ChemMedChem. 2015 Jul;10(7):1184-99. 4. Wang L, Si P, Sheng Y, Chen Y, Wan P, Shen X, Tang Y, Chen LL*, Li W*. Discovery of New Non-Steroidal Farnesoid X Receptor Modulators Through 3D Shape Similarity Search and Structure-Based Virtual Screening. Chem Biol Drug Des. 2015 Apr;85(4):481-7. 5. Xu X, Lu Y, Chen LL*, Chen J, Luo X*, Shen X*. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation. Steroids. 2013 Sep;78(9):813-22 6. Huang H, Yu Y, Gao Z, Zhang Y, Li C, Xu X, Jin H, Yan W, Ma R, Zhu J, Shen X, Jiang H, Chen LL*, Li J*. Discovery and Optimization of 1,3,4-Trisubstituted-pyrazolone Derivatives as Novel, Potent, and Nonsteroidal Farnesoid X Receptor (FXR) Selective Antagonists. J Med Chem. 2012, 55(16):7037-53. |